Paper Details

  1. Home
  2. Paper Details

Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study.

Author: BrzoskaJoseph, FierlbeckGerhard, GausWilhelm, JablonskaStefania, KowalzickLutz, ManskeUwe, MohrPeter, OchsendorfFalk, PilzJosef, RogozinskiThomas, ScholzAlbrecht, WagnerGunnar, WimheuerRolf

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

Interferon beta-1a is a drug that can treat basal cell carcinoma (BCC). It is effective in a large majority of patients and has few side effects.
Paper Details　
Original Abstract of the Article :
Although effective conventional therapies are available to treat basal cell carcinoma (BCC), undesirable side effects, including scarring, and in some cases permanent damage, often occur in problematic areas of the body, especially around the eyes, mouth, and cartilage of the nose and ears. In previ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/12459527

データ提供：米国国立医学図書館（NLM）

Navigating the Sands of Basal Cell Carcinoma: Seeking Effective Treatments

The realm of dermatological research is vast and complex, much like a desert landscape. This study examines [研究手法] for the treatment of basal cell carcinoma (BCC), a common skin cancer. Researchers, like skilled navigators, aimed to [主な目的] using [研究手法]. The study reveals [主要な発見] about the efficacy and safety of [研究手法] for BCC treatment. These findings could provide a valuable resource for dermatologists and patients alike, helping to guide treatment decisions. Notably, [特筆すべき結果や意義] further underscores the potential of this treatment approach.

A Promising New Approach for Basal Cell Carcinoma

This research suggests that [研究結果] might offer a viable alternative for treating BCC. With a success rate of [数値] and a generally well-tolerated safety profile, this treatment approach could be a welcome addition to the dermatologist's toolkit.

Protecting Your Skin: A Journey of Care

Like a camel enduring the sun's harsh rays, protecting your skin from the elements is essential. Regular skin checks, sun protection, and a healthy lifestyle are all key to safeguarding your skin's health. This study highlights the potential of [研究手法] for treating BCC, emphasizing the importance of staying informed and consulting with healthcare professionals for personalized guidance.

Dr.Camel's Conclusion

This study is a valuable addition to the growing body of knowledge about BCC treatment. It suggests that [研究結果] might provide a safer and more effective alternative for patients. The researchers' findings are a reminder that we must continue to explore innovative approaches to treat skin cancer, ensuring that patients have access to the best possible care.
Date :
  1. Date Completed 2003-03-27
  2. Date Revised 2011-11-17
Further Info :

Pubmed ID

12459527

DOI: Digital Object Identifier

12459527

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.